JOSEPH JANKOVIC to Child
This is a "connection" page, showing publications JOSEPH JANKOVIC has written about Child.
Connection Strength
0.933
-
Axial tics in Tourette syndrome and chronic tic disorders. J Neurol. 2024 Nov; 271(11):7232-7238.
Score: 0.053
-
Botulinum Neurotoxin Injections in Children with Self-Injurious Behaviors. Toxins (Basel). 2023 03 23; 15(4).
Score: 0.048
-
Safety and Efficacy of Flexible-Dose Deutetrabenazine in Children and Adolescents With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2128204.
Score: 0.043
-
Botulinum Neurotoxin Injections in Childhood Opisthotonus. Toxins (Basel). 2021 02 12; 13(2).
Score: 0.041
-
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment. Parkinsonism Relat Disord. 2019 10; 67:74-89.
Score: 0.037
-
Real-World Experience With VMAT2 Inhibitors. Clin Neuropharmacol. 2019 Mar/Apr; 42(2):37-41.
Score: 0.036
-
Psychogenic Ophthalmologic Movement Disorders. J Neuropsychiatry Clin Neurosci. 2016; 28(3):195-8.
Score: 0.029
-
Dopa-responsive dystonia--clinical and genetic heterogeneity. Nat Rev Neurol. 2015 Jul; 11(7):414-24.
Score: 0.028
-
Long-term efficacy and safety of fluphenazine in patients with Tourette syndrome. Mov Disord. 2014 Jan; 29(1):126-30.
Score: 0.025
-
Movement disorders in autoimmune diseases. Mov Disord. 2012 Jul; 27(8):935-46.
Score: 0.022
-
Tourette's syndrome in adults. Mov Disord. 2010 Oct 15; 25(13):2171-5.
Score: 0.020
-
Tardive dyskinesia and withdrawal emergent syndrome in children. Expert Rev Neurother. 2010 Jun; 10(6):893-901.
Score: 0.020
-
Motor-phonic tic mimicking essential palatal myoclonus. Mov Disord. 2009 Oct 15; 24(13):2030-2.
Score: 0.019
-
A randomised, double-blind, placebo-controlled study of topiramate in the treatment of Tourette syndrome. J Neurol Neurosurg Psychiatry. 2010 Jan; 81(1):70-3.
Score: 0.019
-
Hemidystonia-hemiatrophy syndrome. Mov Disord. 2009 Mar 15; 24(4):583-9.
Score: 0.018
-
Epidemiology and management of essential tremor in children. Paediatr Drugs. 2009; 11(5):293-307.
Score: 0.018
-
Psychogenic movement disorders in children. Mov Disord. 2008 Oct 15; 23(13):1875-81.
Score: 0.018
-
Malignant Tourette syndrome. Mov Disord. 2007 Sep 15; 22(12):1743-50.
Score: 0.016
-
Candidate locus for chorea and tic disorders at 15q? Pediatr Neurol. 2007 Jul; 37(1):70-3.
Score: 0.016
-
Examination of the SLITRK1 gene in Caucasian patients with Tourette syndrome. Acta Neurol Scand. 2006 Dec; 114(6):400-2.
Score: 0.015
-
Botulinum toxin injection for congenital muscular torticollis presenting in children and adults. Neurology. 2006 Sep 26; 67(6):1083-5.
Score: 0.015
-
Is history of depression a contraindication to treatment with tetrabenazine? Clin Neuropharmacol. 2006 Sep-Oct; 29(5):259-64.
Score: 0.015
-
A functional variant of the dopamine D3 receptor is associated with risk and age-at-onset of essential tremor. Proc Natl Acad Sci U S A. 2006 Jul 11; 103(28):10753-8.
Score: 0.015
-
Globus pallidus deep brain stimulation in dystonia. Mov Disord. 2006 May; 21(5):692-5.
Score: 0.015
-
Tourette's syndrome and the law. J Neuropsychiatry Clin Neurosci. 2006; 18(1):86-95.
Score: 0.014
-
Real-World Experiences with VMAT2 Inhibitors in Pediatric Hyperkinetic Movement Disorders. Tremor Other Hyperkinet Mov (N Y). 2025; 15:26.
Score: 0.014
-
Metoclopramide-induced tardive dyskinesia in an infant. Mov Disord. 2005 Jan; 20(1):86-9.
Score: 0.013
-
Essential tremor among children. Pediatrics. 2004 Nov; 114(5):1203-5.
Score: 0.013
-
Basal ganglia neuronal discharge in primary and secondary dystonia. Adv Neurol. 2004; 94:29-36.
Score: 0.013
-
Clinical heterogeneity of neurodegeneration with brain iron accumulation (Hallervorden-Spatz syndrome) and pantothenate kinase-associated neurodegeneration. Mov Disord. 2004 Jan; 19(1):36-42.
Score: 0.013
-
Migraine headache in patients with Tourette syndrome. Arch Neurol. 2003 Nov; 60(11):1595-8.
Score: 0.012
-
Basal ganglia neuronal discharge in primary and secondary dystonia in patients undergoing pallidotomy. Neurosurgery. 2003 Jun; 52(6):1358-70; discussion 1370-3.
Score: 0.012
-
Paroxysmal kinesigenic dyskinesias. Semin Pediatr Neurol. 2003 Mar; 10(1):68-79.
Score: 0.012
-
Secondary paroxysmal dyskinesias. Mov Disord. 2002 Jul; 17(4):726-34.
Score: 0.011
-
Tourettism and dystonia after subcortical stroke. Mov Disord. 2002 Jul; 17(4):821-5.
Score: 0.011
-
Efficacy and Safety of Fixed-Dose Deutetrabenazine in Children and Adolescents for Tics Associated With Tourette Syndrome: A Randomized Clinical Trial. JAMA Netw Open. 2021 10 01; 4(10):e2129397.
Score: 0.011
-
Re-emergence of childhood stuttering in Parkinson's disease: a hypothesis. Mov Disord. 2001 Jan; 16(1):114-8.
Score: 0.010
-
Botulinum toxin in the treatment of tics. Arch Neurol. 2000 Aug; 57(8):1190-3.
Score: 0.010
-
Botulinum toxin A in patients with oromandibular dystonia: long-term follow-up. Neurology. 1999 Dec 10; 53(9):2102-7.
Score: 0.009
-
Bilineal transmission in Tourette syndrome. Neurology. 1999 Sep 11; 53(4):813-8.
Score: 0.009
-
Bruxism and cranial-cervical dystonia: is there a relationship? Cranio. 1999 Jul; 17(3):196-201.
Score: 0.009
-
Ecopipam, a D1 receptor antagonist, for treatment of tourette syndrome in children: A randomized, placebo-controlled crossover study. Mov Disord. 2018 08; 33(8):1272-1280.
Score: 0.009
-
Post-traumatic movement disorders: effect of the legal system on outcome. J Forensic Sci. 1998 Mar; 43(2):334-9.
Score: 0.008
-
Long-term effects of tetrabenazine in hyperkinetic movement disorders. Neurology. 1997 Feb; 48(2):358-62.
Score: 0.008
-
Delayed-onset progressive movement disorders after static brain lesions. Neurology. 1996 Jan; 46(1):68-74.
Score: 0.007
-
Paroxysmal dyskinesias: clinical features and classification. Ann Neurol. 1995 Oct; 38(4):571-9.
Score: 0.007
-
Deprenyl in attention deficit associated with Tourette's syndrome. Arch Neurol. 1993 Mar; 50(3):286-8.
Score: 0.006
-
The spectrum of movement disorders in children with anti-NMDA receptor encephalitis. Mov Disord. 2013 Apr; 28(4):543-7.
Score: 0.006
-
Mutation screening of the HTR2B gene in patients with Tourette syndrome. Neurosci Lett. 2012 Sep 27; 526(2):150-3.
Score: 0.006
-
The coexistence of tics and dystonia. Arch Neurol. 1991 Aug; 48(8):862-5.
Score: 0.005
-
Cervical dystonia: clinical findings and associated movement disorders. Neurology. 1991 Jul; 41(7):1088-91.
Score: 0.005
-
Dystonic tics in patients with Tourette's syndrome. Mov Disord. 1991; 6(3):248-52.
Score: 0.005
-
The association of Tourette syndrome and dopa-responsive dystonia. Mov Disord. 2011 Feb 01; 26(2):359-60.
Score: 0.005
-
Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry. 1990 Aug; 53(8):633-9.
Score: 0.005
-
Coprophenomena in Tourette syndrome. Dev Med Child Neurol. 2009 Mar; 51(3):218-27.
Score: 0.004
-
Lesch-Nyhan syndrome: a study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol. 1988 May; 23(5):466-9.
Score: 0.004
-
Focal task-specific tremor and dystonia: categorization of occupational movement disorders. Neurology. 1988 Apr; 38(4):522-7.
Score: 0.004
-
Rett syndrome: qualitative and quantitative differentiation from autism. J Child Neurol. 1988; 3 Suppl:S65-7.
Score: 0.004
-
Orofacial and other self-mutilations. Adv Neurol. 1988; 49:365-81.
Score: 0.004
-
Blepharospasm and cranial-cervical dystonia (Meige's syndrome): familial occurrence. Adv Neurol. 1988; 49:117-23.
Score: 0.004
-
Motor, behavioral and pharmacologic findings in Tourette's syndrome. Can J Neurol Sci. 1987 Aug; 14(3 Suppl):541-6.
Score: 0.004
-
The phenomenology of tics. Mov Disord. 1986; 1(1):17-26.
Score: 0.004
-
A heteroplasmic mitochondrial complex I gene mutation in adult-onset dystonia. Neurogenetics. 2003 Aug; 4(4):199-205.
Score: 0.003
-
Intrafamilial phenotypic variability of the DYT1 dystonia: from asymptomatic TOR1A gene carrier status to dystonic storm. Mov Disord. 2002 Mar; 17(2):339-45.
Score: 0.003
-
Identification of a high frequency of mutation at exon 8 of the ATP7B gene in a Chinese population with Wilson disease by fluorescent PCR. Arch Neurol. 2001 Nov; 58(11):1879-82.
Score: 0.003
-
Comparison of thalamotomy and pallidotomy for the treatment of dystonia. Neurosurgery. 2001 Apr; 48(4):818-24; discussion 824-6.
Score: 0.003
-
Pallidotomy for generalized dystonia. Mov Disord. 1998 Jul; 13(4):693-8.
Score: 0.002
-
Outcome after stereotactic thalamotomy for dystonia and hemiballismus. Neurosurgery. 1995 Mar; 36(3):501-7; discussion 507-8.
Score: 0.002
-
Rett syndrome: controlled study of an oral opiate antagonist, naltrexone. Ann Neurol. 1994 Apr; 35(4):464-70.
Score: 0.002
-
Extrapyramidal involvement in Rett's syndrome. Neurology. 1990 Feb; 40(2):293-5.
Score: 0.001
-
Rett syndrome and associated movement disorders. Mov Disord. 1990; 5(3):195-202.
Score: 0.001